Targeting the tumour stroma: Phenomic AI launches with $6m seed financing
Toronto-headquartered Phenomic AI has launched with $6m in seed funding. The round was led by CTI Life Sciences Fund, while…
Latest Deals Analysis
-
6 days
-
6 days
-
1 week
-
2 weeks
-
6 days
-
6 days
-
1 week
-
2 weeks
Breaking the taboo: disrupting the fertility sector
Infertility, defined by the World Health Organization as a disease of the reproductive system that results in disability, has long…
Latest News
View More
Dr Reddy’s and RDIF receive DCGI approval for Sputnik V human trial
Dr Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) have received approval from the Drug Control General of India (DCGI) to conduct a Phase II…
Pfizer to seek approval for Covid-19 vaccine candidate next month
Pfizer has announced plans to submit an application to the US Food and Drug Administration (FDA) seeking approval for its Covid-19 vaccine candidate next month.…
Eli Lilly to acquire biotechnology company Disarm Therapeutics
Eli Lilly has entered a definitive agreement to acquire biotech firm Disarm Therapeutics for an upfront payment of $135m. Under…
ImmunityBio receives FDA authorisation for Phase I Covid-19 vaccine trial
ImmunityBio has received authorisation from the US Food and Drug Administration (FDA) to initiate a Phase I trial of its…
FDA approves Regeneron’s Inmazeb for Ebola infection treatment
The US Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals’ Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) to treat Ebola virus…
Targeting the tumour stroma: Phenomic AI launches with $6m seed financing
Toronto-headquartered Phenomic AI has launched with $6m in seed funding. The round was led by CTI Life Sciences Fund, while…
Company A-Z
View More
SIRION Biotech
Customised Viral Vectors for Cell Modelling, Gene Therapy, and Vaccination Research and Development
Cytiva (formerly GE Life Sciences)
Bioprocessing Solutions for Development and Manufacture of Biotherapeutics and Vaccines
Latest Content
View More
Protein misfolding and neurodegeneration: Yumanity and Proteostasis merger
Two Boston-based companies, Yumanity Therapeutics and Proteostasis Therapeutics, have signed a merger agreement. As a result of this merger, which…
Treating food allergies: Nestlé Health Science’s $2.6bn acquisition of Aimmune
Nestlé’s nutritional science brand Nestlé Health Science (NHSc) is to acquire California-based Aimmune Therapeutics. The acquisition is priced at $34.50…
Softigel by Procaps Announces New Website Launch
Softigel by Procaps, a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the pharmaceutical and…
Six Steps to Handle High-Potent Molecules in a Shared Facility
In recent years, the development of highly potent molecules has become more frequent, and around 25% of the components that…
Samsung Biologics’ P4 Super Plant, Songdo
Samsung Biologics is planning to expand its manufacturing facilities with the construction of its fourth biopharmaceutical manufacturing plant, P4-Super Plant,…
Micronova Bags and Liners for Containment Functions in Cleanroom Areas
Bio/pharma, compounding pharmacies and other life science industries are continually attempting to minimise material contamination. As a result, The need…